Douglas Blayney is listed as a director on 14 SEC Form D filings by 1 issuer between Apr 2018 and Apr 2026: ARTELO BIOSCIENCES, INC. (Solana Beach, CA — biotechnology — 2018–2026; $11M reported sold to 59 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Connie Matsui (14 shared filings), Gregory D. Gorgas (14 shared filings), R. Martin Emanuele (14 shared filings), Steven Kelly (14 shared filings), Gregory R. Reyes (9 shared filings) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Douglas. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 14 public filings for Douglas Blayney and found 6 differences, 1 worth asking the sponsor about: Form D filed 147 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.